Meningococcal Disease: Resources and Publications
|Related Pages: Disease FAQs | Technical and Clinical Information|
- Report from the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2--10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4) May 2, 2008; MMWR Vol. 57, No 17;462-465
- Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008 February 22, 2008: MMWR 57(07);173-175
- Revised ACIP Recommendations August 10, 2007 Vol 56 No. 31
- ACIP Recommendations May 27, 2005 / Vol. 54 / No. RR-7
- Serogroup W-135 Meningococcal Disease Among Travelers Returning From Saudi Arabia -- United States, 2000 MMWR Vol. 49, No 16;345-6
- CDC. Meningococcal Disease -- New England, 1993 - 1998. ( PDF -28 pages) (HTML version) MMWR Vol 48:629-33 (7/30/99)
- CDC. Change in Recommendation for Meningococcal Vaccine for Travelers ( PDF - 20 pages)
(HTML version) MMWR Vol 48, No 05;104. (2/12/99)
Note: You need to scroll to this section of the document.
- CDC. Lab-Based Surveillance for Meningococcal Disease -- U.S., 1989-91
MMWR Vol 42 (SS-2):21-30 (6/4/93)
- Control and Prevention of Meningococcal Disease and Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks ( PDF - 27 pages) (HTML version)
MMWR Vol 46 (RR-5):1-51 (2/14/97)
- Serogroup Y Meningococcal Disease -- Illinois, Connecticut, and Selected Areas, United States, 1989-1996 ( PDF - 24 pages) (HTML version)
MMWR Vol. 45, No. 46;1010-1014 (11/22/96)
Note: You need to scroll to this section of the document.
- Serogroup B Meningococcal Disease -- Oregon, 1994 ( PDF - 24 pages) (HTML version)
MMWR Vol. 45 / No. 4621-124
- Which vaccines do pre-teens/adolescents need?
- Questions and Answers about Pre-teen Vaccines
- AAP recommendations for control of meningococcal disease
- CDC's Active Bacterial Core Surveillance (ABCs) website
- ACIP recommendations
- American College Health Association website
- Case Definitions for InfectiousConditions Under Public Health Surveillance
Guidelines for travelers
- CDC's travel website
- CDC travelers health Yellow Book
- Integrated Disease Surveillance and Response (IDSR)
Recommendations for meningococcal disease and airplanes
- Exposure to Patients With Meningococcal Disease on Aircrafts --United States, 1999-2001 MMWR: June 15, 2001 / 50(23);485-9
- Laboratory Methods for the Diagnosis of Meningitis - Manual
- Prevention strategies for immunizations for vaccine - preventable diseases, isolation precautions to prevent exposures to infectious agents, management of health care personnel exposure to infected persons.
- United Kingdom health Education Authority site for Conjugate Mening C campaign (exit site)
- Vaccine Information - Meningococcal Disease
- Vaccine Information Sheet
- Vaccine safety
- WHO website that includes link to get the control of epidemic meningococcal disease (exit site)
Borrow R, Carlone GM, Rosenstein N, Blake M, Feavers I, Martin D, Zollinger W, Stephens DS, and The Meningococcal Working Group. Neisseria meningitidis group B correlates of protection and assay standardization – International Meeting Report, Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine 2006;24:5093-107.
Dull P, Abdelwahab J, Sacchi C, Becker M, Noble C, Kaiser R, Mayer L, Whitney A, Schmink S, Dolan-Livengood J, Stephens DS, Ajello G, Creton M, Popovic T, Rosenstein N. Serogroup W-135 Neisseria meningitidis carriage among U.S. travelers to the 2001 Hajj. J Infect Dis 2005;191:33-9.
Rainbow J, Cebelinski E, Bartkus J, Glennen A, Boxrud D, Lynfield R. Rifampin-resistant meningoccal disease . Emerg Infect Dis 2005;11(6):977-9.
Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins B, Rosenstein NA. Assessing the risk of laboratory-acquired meningococcal disease in the United States, 1996-2000. J Clin Microbiol 2005;24:4811-4.
Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 2005;115(5):1220-32.
McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn A, Pacheco AGF, Shutt KA, Razeq J, Harrison LH. Epidemiologic trends and genotypes causing meningococcal disease, Maryland . Emerg Infect Dis 2004;10:451-6.
Mothershed EA, Sacchi CT, Whitney AM, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitis. J Clin Microbiol 2004 (Jan).
Shepard CW, Rosenstein NE, Fischer M, and the Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990-1999. Pediatr Infect Dis J, 2003;22:418-22.
Kellerman S, McCombs K, Ray M, Farley MM, Rosenstein N, Popovic T, Blake P, Stephens DS, and the Georgia Emerging Infections Program. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis 2002;186:40-8.
Ohuabunwo C, Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N. Progress Toward Elimination of Haemophilus influenzae Type b Invasive Disease Among Infants and Children, United States, 1998--2000. MMWR Morb Mortal Wkly Rep 2002; 51(11); 234-7.
Rosenstein N, Perkins B, Stephens D, Popovic T, Hughes J. Meningococcal disease. NEJM 2001; 344: 1378-1388.
Sacchi C, Whitney A, Popovic T, et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000; 182: 1169-1176.
CDC. Meningococcal vaccine and college students: recommendations of the Advisory Committee on Immunization Practices. MMWR 2000; 49 (RR-7): 11-20.
Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux J. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bull World Health Organ 1999; 77: 499-508.
CDC. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (No. RR-05): 1-21.
.pdf files: To view and print the .pdf files on this site, you will need Adobe Acrobat Reader. Use this link to obtain a free copy of Adobe Acrobat Reader (exit). We highly recommend that you upgrade to the latest version if haven't already.
Content last reviewed on May 28, 2008
Content Source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases